LD-2 Disclosure Form

Page 1 of 5

Clerk of the House of Representatives Legislative Resource Center B-106 Cannon Building Washington, DC 20515 http://lobbyingdisclosure.house.gov

Secretary of the Senate Office of Public Records 232 Hart Building Washington, DC 20510 http://www.senate.gov/lobby

LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page 1. Registrant Name Organization/Lobbying Firm St. Jude Medical, Inc.

Self Employed Individual

2. Address Address1 1 Massachusetts Ave., NW City

Address2 Suite 330

Washington

State DC

Zip Code

State

Zip Code

20001

Country

USA

3. Principal place of business (if different than line 2) City 4a. Contact Name Mrs. ASHLI J. DOUGLAS 7. Client Name

Self

Country

b. Telephone Number c. E-mail 2023841360 [email protected] Check if client is a state or local government or instrumentality

St. Jude Medical, Inc.

TYPE OF REPORT

8. Year 2013

Q1 (1/1 - 3/31)

Q2 (4/1 - 6/30)

9. Check if this filing amends a previously filed version of this report Termination Date 10. Check if this is a Termination Report

Q3 (7/1 - 9/30)

5. Senate ID# 40006041-12 6. House ID# 397490000 Q4 (10/1 - 12/31)

11. No Lobbying Issue Activity

INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 12. Lobbying INCOME relating to lobbying activities for this reporting period was: Less than $5,000 $5,000 or more

13. Organizations EXPENSE relating to lobbying activities for this reporting period were: Less than $5,000

$

$5,000 or more

$ 160,000.00

Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income from the client (including all payments to 14. REPORTING Check box to indicate expense accounting the registrant by any other entity for lobbying activities on behalf of method. See instructions for description of options. the client). Method A. Reporting amounts using LDA definitions only Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code Signature

Digitally Signed By: Ashli J. Douglas, Sr. Director, Government Affairs

Date

05/10/2013

http://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=647d82ca-45c5-46... 4/30/2014

LD-2 Disclosure Form

Page 2 of 5

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code TAX 16. Specific lobbying issues

Support legislation to repeal the medical device excise tax, specifically HR 523, The Protect Medical Innovation Act. General support for corporate tax reform, including hybrid territorial tax reform. 17. House(s) of Congress and Federal agencies

Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE 18. Name of each individual who acted as a lobbyist in this issue area First Name

Last Name

Ashli

Douglas

Suffix

19. Interest of each foreign entity in the specific issues listed on line 16 above

Covered Official Position (if applicable)

New

Check if None

http://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=647d82ca-45c5-46... 4/30/2014

LD-2 Disclosure Form

Page 3 of 5

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code MMM 16. Specific lobbying issues

General implementation issues with the Affordable Care Act: ACO's, physician disclosure 17. House(s) of Congress and Federal agencies

Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE 18. Name of each individual who acted as a lobbyist in this issue area First Name

Last Name

Ashli

Douglas

Suffix

19. Interest of each foreign entity in the specific issues listed on line 16 above

Covered Official Position (if applicable)

New

Check if None

http://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=647d82ca-45c5-46... 4/30/2014

LD-2 Disclosure Form

Page 4 of 5

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code NAT 16. Specific lobbying issues

Support The Responsible Helium Administration and Stewardship Act (H.R. 527) to allow the Bureau of Land Management to sell helium from the Federal Helium Reserve. 17. House(s) of Congress and Federal agencies

Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE 18. Name of each individual who acted as a lobbyist in this issue area First Name

Last Name

Ashli

Douglas

Suffix

Covered Official Position (if applicable)

19. Interest of each foreign entity in the specific issues listed on line 16 above

New

Check if None

Information Update Page - Complete ONLY where registration information has changed. 20. Client new address Address City

State

Zip Code

Country

State

Zip Code

Country

21. Client new principal place of business (if different than line 20) City 22. New General description of client’s business or activities

LOBBYIST UPDATE 23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name

Last Name

Suffix

First Name

1

3

2

4

Last Name

Suffix

ISSUE UPDATE

http://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=647d82ca-45c5-46... 4/30/2014

LD-2 Disclosure Form

Page 5 of 5

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS 25. Add the following affiliated organization(s) Internet Address: Address Street Address City

Name

State/Province Zip

Principal Place of Business (city and state or country)

Country City State

Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1

2

3

FOREIGN ENTITIES 27. Add the following foreign entities:

Name

Address Street Address City State/Province Country

Principal place of business (city and state or country) City State

Amount of Ownership contribution for percentage in lobbying activities client

Country

%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1

3

5

2

4

6

http://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=647d82ca-45c5-46... 4/30/2014

Clerk of the House of Representatives Legislative Resource Center B-106 Cannon Building Washington, DC 20515

Secretary of the Senate Office of Public Records 232 Hart Building Washington, DC 20510

http://lobbyingdisclosure.house.gov

http://www.senate.gov/lobby

LOBBYING REPORT Lobbying Disclosure Act of 1995 (Section 5)

- All Filers Are Required to Complete This Page

1. Registrant Name

Self Employed Individual

Organization/Lobbying Firm

St. Jude Medical, Inc.

2. Address

Check if different than previously reported

Address1 1 Massachusetts Ave., NW City

Address2 Suite 330

Washington

State

DC

Zip Code 20001

-

Country

Zip Code

-

Country

USA

3. Principal place of business (if different than line 2) State

City 4a. Contact Name

b. Telephone Number c. E-mail

5. Senate ID#

International Number

Mrs.

(202) 384-1360

ASHLI J. DOUGLAS

Self

7. Client Name

40006041-12

[email protected]

6. House ID#

Check if client is a state or local government or instrumentality

397490000

St. Jude Medical, Inc.

TYPE OF REPORT

8. Year 2013

Q1 (1/1 - 3/31)

Q2 (4/1 - 6/30)

Q3 (7/1-9/30)

Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report 10. Check if this is a Termination Report

INCOME OR EXPENSES

Termination Date

11. No Lobbying Issue Activity

- YOU MUST complete either Line 12 or Line 13

12. Lobbying

13. Organizations

INCOME relating to lobbying activities for this reporting period was:

EXPENSE relating to lobbying activities for this reporting period were:

Less than $5,000

Less than $5,000

$5,000 or more

$

Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income from the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client).

$5,000 or more

$ 180,000.00

Check box to indicate expense 14. REPORTING accounting method. See instructions for description of options. Method A.

Reporting amounts using LDA definitions only

Method B.

Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature

Digitally Signed By: Ashli Douglas

Printed Name and Title v6.0.3a

Date

11/19/2013

Ashli Douglas, Sr. Director, Government Affairs Page 1 of 3

Registrant

St. Jude Medical, Inc.

Client Name

St. Jude Medical, Inc.

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code

TAX

Taxation/Internal Revenue Code

(one per page)

16. Specific lobbying issues Issues related to R&D tax rredit and corporate/international tax proposals Support repeal of medical device excise tax

17. House(s) of Congress and Federal agencies

Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area First Name

Last Name

Ashli

Douglas

Suffix

19. Interest of each foreign entity in the specific issues listed on line 16 above

Printed Name and Title v6.0.3a

Covered Official Position (if applicable)

New

Check if None

Ashli Douglas, Sr. Director, Government Affairs Page 2 of 3

Registrant

St. Jude Medical, Inc.

Client Name

St. Jude Medical, Inc.

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code

NAT

(one per page)

Natural Resources

16. Specific lobbying issues Support reauthorization of bureau of land management national helium reserves program

17. House(s) of Congress and Federal agencies

Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area First Name

Last Name

Ashli

Douglas

Suffix

19. Interest of each foreign entity in the specific issues listed on line 16 above

Printed Name and Title v6.0.3a

Covered Official Position (if applicable)

New

Check if None

Ashli Douglas, Sr. Director, Government Affairs Page 3 of 3

LD-2 Disclosure Form

Page 1 of 4

Clerk of the House of Representatives Legislative Resource Center B-106 Cannon Building Washington, DC 20515 http://lobbyingdisclosure.house.gov

Secretary of the Senate Office of Public Records 232 Hart Building Washington, DC 20510 http://www.senate.gov/lobby

LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page 1. Registrant Name Organization/Lobbying Firm St. Jude Medical, Inc.

Self Employed Individual

2. Address Address1 1 Massachusetts Ave., NW City

Address2 Suite 330

Washington

State DC

Zip Code

State

Zip Code

20001

Country

USA

3. Principal place of business (if different than line 2) City 4a. Contact Name Mrs. ASHLI J. DOUGLAS 7. Client Name

Self

Country

b. Telephone Number c. E-mail 2023841360 [email protected] Check if client is a state or local government or instrumentality

St. Jude Medical, Inc.

TYPE OF REPORT

8. Year 2013

Q1 (1/1 - 3/31)

Q2 (4/1 - 6/30)

9. Check if this filing amends a previously filed version of this report Termination Date 10. Check if this is a Termination Report

Q3 (7/1 - 9/30)

5. Senate ID# 40006041-12 6. House ID# 397490000 Q4 (10/1 - 12/31)

11. No Lobbying Issue Activity

INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 12. Lobbying INCOME relating to lobbying activities for this reporting period was: Less than $5,000 $5,000 or more

13. Organizations EXPENSE relating to lobbying activities for this reporting period were: Less than $5,000

$

$5,000 or more

$ 140,000.00

Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income from the client (including all payments to 14. REPORTING Check box to indicate expense accounting the registrant by any other entity for lobbying activities on behalf of method. See instructions for description of options. the client). Method A. Reporting amounts using LDA definitions only Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code Signature

Digitally Signed By: Ashli Douglas, Sr. Director, Government Affairs

Date

11/19/2013

http://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=c6d49203-fbfc-448... 4/30/2014

LD-2 Disclosure Form

Page 2 of 4

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code TAX 16. Specific lobbying issues

Issues related to R&D tax credit and corporate/international tax proposals Support repeal of medical device excise tax 17. House(s) of Congress and Federal agencies

Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE 18. Name of each individual who acted as a lobbyist in this issue area First Name

Last Name

Ashli

Douglas

Suffix

19. Interest of each foreign entity in the specific issues listed on line 16 above

Covered Official Position (if applicable)

New

Check if None

http://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=c6d49203-fbfc-448... 4/30/2014

LD-2 Disclosure Form

Page 3 of 4

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code NAT 16. Specific lobbying issues

Support reauthorization of bureau of land management national helium reserves program 17. House(s) of Congress and Federal agencies

Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE 18. Name of each individual who acted as a lobbyist in this issue area First Name

Last Name

Ashli

Douglas

Suffix

Covered Official Position (if applicable)

19. Interest of each foreign entity in the specific issues listed on line 16 above

New

Check if None

Information Update Page - Complete ONLY where registration information has changed. 20. Client new address Address City

State

Zip Code

Country

State

Zip Code

Country

21. Client new principal place of business (if different than line 20) City 22. New General description of client’s business or activities

LOBBYIST UPDATE 23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name

Last Name

Suffix

First Name

1

3

2

4

Last Name

Suffix

ISSUE UPDATE

http://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=c6d49203-fbfc-448... 4/30/2014

LD-2 Disclosure Form

Page 4 of 4

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS 25. Add the following affiliated organization(s) Internet Address: Address Street Address City

Name

State/Province Zip

Principal Place of Business (city and state or country)

Country City State

Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1

2

3

FOREIGN ENTITIES 27. Add the following foreign entities:

Name

Address Street Address City State/Province Country

Principal place of business (city and state or country) City State

Amount of Ownership contribution for percentage in lobbying activities client

Country

%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1

3

5

2

4

6

http://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=c6d49203-fbfc-448... 4/30/2014

LD-2 Disclosure Form

Page 1 of 5

Clerk of the House of Representatives Legislative Resource Center B-106 Cannon Building Washington, DC 20515 http://lobbyingdisclosure.house.gov

Secretary of the Senate Office of Public Records 232 Hart Building Washington, DC 20510 http://www.senate.gov/lobby

LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page 1. Registrant Name Organization/Lobbying Firm St. Jude Medical, Inc.

Self Employed Individual

2. Address Address1 1 Massachusetts Ave., NW City

Address2 Suite 330

Washington

State DC

Zip Code

State

Zip Code

20001

Country

USA

3. Principal place of business (if different than line 2) City 4a. Contact Name Mrs. ASHLI J. DOUGLAS 7. Client Name

Self

Country

b. Telephone Number c. E-mail 2023841360 [email protected] Check if client is a state or local government or instrumentality

St. Jude Medical, Inc.

TYPE OF REPORT

8. Year 2013

Q1 (1/1 - 3/31)

Q2 (4/1 - 6/30)

9. Check if this filing amends a previously filed version of this report Termination Date 10. Check if this is a Termination Report

Q3 (7/1 - 9/30)

5. Senate ID# 40006041-12 6. House ID# 397490000 Q4 (10/1 - 12/31)

11. No Lobbying Issue Activity

INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 12. Lobbying INCOME relating to lobbying activities for this reporting period was: Less than $5,000 $5,000 or more

13. Organizations EXPENSE relating to lobbying activities for this reporting period were: Less than $5,000

$

$5,000 or more

$ 140,000.00

Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income from the client (including all payments to 14. REPORTING Check box to indicate expense accounting the registrant by any other entity for lobbying activities on behalf of method. See instructions for description of options. the client). Method A. Reporting amounts using LDA definitions only Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code Signature

Digitally Signed By: Ashli J. Douglas, Sr. Director, Government Affairs

Date

http://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=37504fb9-4313-4f...

01/24/2014

4/30/2014

LD-2 Disclosure Form

Page 2 of 5

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code TAX 16. Specific lobbying issues

Support repeal of the medical device tax HR 523/S. 232 Support R&D Tax credit extension 17. House(s) of Congress and Federal agencies

Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE 18. Name of each individual who acted as a lobbyist in this issue area First Name

Last Name

Ashli

Douglas

Suffix

19. Interest of each foreign entity in the specific issues listed on line 16 above

Covered Official Position (if applicable)

New

Check if None

http://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=37504fb9-4313-4f...

4/30/2014

LD-2 Disclosure Form

Page 3 of 5

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code HCR 16. Specific lobbying issues

Support H.R. 2725, the FDA SOS Act legislation proposing to permanently exempt FDA user fees from sequestration and related legislation to release existing sequestered fees. 17. House(s) of Congress and Federal agencies

Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name

Last Name

Ashli

Douglas

Suffix

19. Interest of each foreign entity in the specific issues listed on line 16 above

Covered Official Position (if applicable)

New

Check if None

http://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=37504fb9-4313-4f...

4/30/2014

LD-2 Disclosure Form

Page 4 of 5

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code LAW 16. Specific lobbying issues

Protecting American Trade Secrets and Innovation Act of 2013 17. House(s) of Congress and Federal agencies

Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name

Last Name

Ashli

Douglas

Suffix

Covered Official Position (if applicable)

19. Interest of each foreign entity in the specific issues listed on line 16 above

New

Check if None

Information Update Page - Complete ONLY where registration information has changed. 20. Client new address Address City

State

Zip Code

Country

State

Zip Code

Country

21. Client new principal place of business (if different than line 20) City 22. New General description of client’s business or activities

LOBBYIST UPDATE 23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name

Last Name

Suffix

First Name

1

3

2

4

Last Name

Suffix

ISSUE UPDATE

http://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=37504fb9-4313-4f...

4/30/2014

LD-2 Disclosure Form

Page 5 of 5

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS 25. Add the following affiliated organization(s) Internet Address: Address Street Address City

Name

State/Province Zip

Principal Place of Business (city and state or country)

Country City State

Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1

2

3

FOREIGN ENTITIES 27. Add the following foreign entities:

Name

Address Street Address City State/Province Country

Principal place of business (city and state or country) City State

Amount of Ownership contribution for percentage in lobbying activities client %

Country

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1

3

5

2

4

6

http://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=37504fb9-4313-4f...

4/30/2014